Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |